Infectious Disease Diagnostics Testing Market 2025-2034: Key Highlights, Growth Dynamics, and Emerging Trends
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Are the Key Projections for the CAGR of the Infectious Disease Diagnostics Testing Market Size From 2025 to 2034?
There has been a significant expansion in the market size of infectious disease diagnostics testing in the most recent years. The market, which was valued at $38.52 billion in 2024, is projected to increase to $42.24 billion in 2025, representing a compound annual growth rate (CAGR) of 9.7%. This historical growth can be largely attributed to the surge in disease outbreaks such as SARS, Ebola, and Zika, an enhanced awareness among medical professionals and the broader public about the critical need for early diagnosis and prevention of infectious diseases, a rise in disease control, surveillance, and prevention programs funded by governments, a spike in global trade and travel that has accelerated the transmission of infectious diseases and elevated healthcare expenditure, particularly in developing economies.
Expectations are high for substantial growth in the market size for infectious disease diagnostics testing in the approaching years. It’s projected to escalate to $60.71 billion in 2029, with a compound annual growth rate (CAGR) of 9.5%. The predicted growth in this period can be linked to several factors. These include the ongoing discovery of new pathogens, including new variants of influenza or COVID-19, the transition towards personalized medicine and targeted treatments, increased need for swift and local testing solutions, an intensified focus on epidemiological surveillance and early detection systems, and a rise in research and development endeavors aiming at creating new diagnostic techniques and biomarkers. Key trends for the forecast period encompass the miniaturization and mobility of diagnostic gadgets, the implementation of multiplex assays that can identify various pathogens at once, inclusion of digital health solutions like mobile applications and telemedicine platforms, the utilization of next-generation sequencing (NGS) technologies in infectious disease diagnostics, progress in biosensor technologies facilitating quick and sensitive identification of infectious diseases, and the incorporation of AI and machine learning algorithms into diagnostic systems.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15831&type=smp
Which Primay Drivers Are Accelerating Growth in the Infectious Disease Diagnostics Testing Market?
The upward trend in respiratory infections is projected to drive the infectious disease diagnostic testing market’s expansion. These infections, which affect the respiratory system including the nose, throat, airways, and lungs, are on the rise due to viral and bacterial transmission via close contact with infected people, poor sanitary practices, overcrowded living situations, and seasonal weather fluctuations. The crucial role of infectious disease diagnostic testing in pinpointing pathogens such as viruses and bacteria in patient samples makes it indispensable for diagnosing and treating respiratory infections. To illustrate, in February 2024, the Canadian Institute for Health Information, a non-profit based in Canada, reported a 32% increase in hospitalizations for acute upper respiratory infections, going from 2,114 cases in 2022 up to 2,797 in 2023. As a result, the infectious disease diagnostic testing market is being propelled by the surge in respiratory infections.
Which Primary Segments of the Infectious Disease Diagnostics Testing Market Are Driving Growth and Industry Transformations?
The infectious disease diagnostics testingmarket covered in this report is segmented –
1) By Type: Molecular Diagnostic Test, Point Of Care Tests (POCT) Infectious Disease Diagnostics Test
2) By Application: Respiratory, Human Immunodeficiency Virus (HIV), Healthcare-Associated Infections (HAIs), Sexual Health, Tropical Diseases, Liver
3) By End-User: Diagnostic Laboratories, Hospitals And Clinics, Academic Research Institutes, Other End-Users
Subsegments:
1) By Molecular Diagnostic Test: Polymerase Chain Reaction (PCR) Tests, Nucleic Acid Amplification Tests (NAATs), Next-Generation Sequencing (NGS), Microarray-Based Tests
2) By Point Of Care Tests (POCT) Infectious Disease Diagnostics Test: Lateral Flow Assays, Rapid Antigen Tests, Immunoassays, Portable PCR
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=15831&type=smp
Which Regions Are Key Players in the Growth of the #Which Primay Drivers Are Accelerating Growth in the Infectious Disease Diagnostics Testing Market?# Market?
North America was the largest region in the infectious disease diagnostics testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the infectious disease diagnostics testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Which Technological Trends Are Reshaping the Infectious Disease Diagnostics Testing Industry Dynamics?
Leading enterprises in the infectious disease diagnostic testing market are prioritizing the advancement of novel technologies, such as molecular diagnostics platforms, to maintain their competitive standing. These platforms are intricate systems engineered to detect and examine nucleic acids (DNA or RNA) from biological specimens for diagnostic objectives. For example, in May 2022, Becton Dickinson, a US-based medical technology firm and Company, introduced the BD COR System. This is a fully integrated, high-capacity infectious disease molecular diagnostics platform that automates the entire molecular lab workflow from sample management to obtaining diagnostic results, thereby eliminating manual specimen sorting and allowing lab technicians to focus on more specialized tasks. The platform is capable of processing up to 1,700 specimens and providing results within 24 hours, demonstrating its high-capacity processing capabilities and sophisticated genotyping for diseases, including HPV and STIs.
View the full report here:
What Parameters Are Used to Define the Infectious Disease Diagnostics Testing Market?
Infectious disease diagnostics testing refers to the process of identifying the presence of pathogens, such as bacteria, viruses, fungi, or parasites, in a patient’s body. These tests are crucial for diagnosing infectious diseases and guiding appropriate treatment decisions. Infectious disease diagnostics testing plays a vital role in controlling the spread of infectious diseases, guiding treatment decisions, and monitoring outbreaks.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15831
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
